Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Biomater Adv ; 162: 213919, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38861801

RESUMEN

Tumor microenvironment (TME)-responsive chemodynamic therapy (CDT) is severely hindered by insufficient intracellular H2O2 level that seriously deteriorates antitumor efficacy, albeit with its extensively experimental and theoretical research. Herein, we designed atomically dispersed FeCo dual active sites anchored in porous carbon polyhedra (termed FeCo/PCP), followed by loading with glucose oxidase (GOx) and anticancer doxorubicin (DOX), named FeCo/PCP-GOx-DOX, which converted glucose into toxic hydroxyl radicals. The loaded GOx can either decompose glucose to self-supply H2O2 or provide fewer nutrients to feed the tumor cells. The as-prepared nanozyme exhibited the enhanced in vitro cytotoxicity at high glucose by contrast with those at less or even free of glucose, suggesting sufficient accumulation of H2O2 and continual transformation to OH for CDT. Besides, the FeCo/PCP-GOx-DOX can subtly integrate starvation therapy, the FeCo/PCP-initiated CDT, and DOX-inducible chemotherapy (CT), greatly enhancing the therapeutic efficacy than each monotherapy.


Asunto(s)
Doxorrubicina , Glucosa Oxidasa , Peróxido de Hidrógeno , Peróxido de Hidrógeno/metabolismo , Peróxido de Hidrógeno/química , Doxorrubicina/farmacología , Doxorrubicina/química , Doxorrubicina/uso terapéutico , Glucosa Oxidasa/metabolismo , Glucosa Oxidasa/química , Humanos , Animales , Microambiente Tumoral/efectos de los fármacos , Ratones , Antineoplásicos/farmacología , Antineoplásicos/química , Antineoplásicos/uso terapéutico , Línea Celular Tumoral , Neoplasias/tratamiento farmacológico , Glucosa/metabolismo , Dominio Catalítico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...